Literature DB >> 27532818

Derivation of Transgene-Free Induced Pluripotent Stem Cells from a Single Drop of Blood.

Hong Yu Chen1, Hong-Kee Tan1, Yuin-Han Loh1,2.   

Abstract

Human-induced pluripotent stem cells (hiPSCs) have great potential for future use in therapeutic regenerative medicine. Based on the current protocol for deriving hiPSCs, invasive procedures such as skin biopsies and venipuncture are required for obtaining donor samples. Herein, we present a detailed protocol for deriving hiPSCs from human finger-prick (FP) blood. In this method, the transgene-free hiPSCs can be easily generated from only 10 µl of FP blood. The finger-pricked iPSCs (FPiPSCs) show all the pluripotency markers and can be easily differentiated into various cell lineages. The time required for deriving the FPiPSCs is relatively short-10 to 15 days for FP blood expansion and 20 to 30 days for reprogramming. This method can be easily adapted for setting up a large scale iPSC bank as it requires only 10 µl of the donor FP blood, which can be easily collected. © 2016 by John Wiley & Sons, Inc.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  iPSC banking; induced pluripotent stem cell; reprogramming; transgene free iPSCs

Mesh:

Year:  2016        PMID: 27532818     DOI: 10.1002/cpsc.12

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  4 in total

1.  Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521.

Authors:  Christian Skorik; Nathaniel K Mullin; Michael Shi; Yosra Zhang; Phoebe Hunter; Yang Tang; Brianna Hilton; Thorsten M Schlaeger
Journal:  Curr Protoc Stem Cell Biol       Date:  2020-03

Review 2.  Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside.

Authors:  Daniele Focosi; Giovanni Amabile
Journal:  Cells       Date:  2017-12-27       Impact factor: 6.600

3.  A Scalable Suspension Platform for Generating High-Density Cultures of Universal Red Blood Cells from Human Induced Pluripotent Stem Cells.

Authors:  Jaichandran Sivalingam; Yu SuE; Zhong Ri Lim; Alan T L Lam; Alison P Lee; Hsueh Lee Lim; Hong Yu Chen; Hong Kee Tan; Tushar Warrier; Jing Wen Hang; Nazmi B Nazir; Andy H M Tan; Laurent Renia; Yuin Han Loh; Shaul Reuveny; Benoit Malleret; Steve K W Oh
Journal:  Stem Cell Reports       Date:  2020-12-10       Impact factor: 7.765

4.  Kidney organoids generated from erythroid progenitors cells of patients with autosomal dominant polycystic kidney disease.

Authors:  Roberta Facioli; Fernando Henrique Lojudice; Ana Carolina Anauate; Edgar Maquigussa; José Luiz Nishiura; Ita Pfeferman Heilberg; Mari Cleide Sogayar; Mirian Aparecida Boim
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.